What does Revvity do?

Revvity (RVTY) is a Health Care Equipment company. Revvity sells life-sciences instruments, reagents, software, and diagnostic tests used in research and clinical labs, with a focus on reproductive health and immunodiagnostics. The company was renamed from PerkinElmer in 2023 and markets products in more than 160 countries. It was founded in 1937, is headquartered in Waltham, Massachusetts and employs about 11,000 people.

How does Revvity make money?

As of 2026-Q3, Revvity's revenue breaks down across Diagnostics (51%), Life Sciences (49%). See the revenue-by-segment chart for the full mix.

How has Revvity's revenue and profitability trended?

Track Revvity's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.

Who are Revvity's main competitors?

Sterling groups Revvity in the Healthcare sector, alongside Agilent Technologies (A), Charles River Laboratories (CRL), Danaher Corporation (DHR), IQVIA (IQV), Mettler Toledo (MTD) and Bio-Techne (TECH).

If I'm investing in Revvity, what similar companies should I consider?

If you are researching Revvity, also look at Agilent Technologies (A), Charles River Laboratories (CRL) and Danaher Corporation (DHR). You can compare all of them side by side or browse the full Healthcare sector on Sterling.